Document Type : Original Article

Authors

1 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

2 Department of Public Health, Abadan Faculty of Medical Sciences, Abadan, Iran

3 Bahar health network, Hamedan University of Medical Sciences, Hamedan, Iran

4 Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

5 Abadan Faculty of Medical Sciences, Abadan, Iran, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Background: COVID-19 emerged in China for the first time, and spread rapidly in the world and in Iran. It caused the death of many people. This study was performed to estimate the years of life lost due to COVID-19 in southwestern Iran.
Methods: In this cross-sectional study, deaths due to COVID-19 were investigated from February 20, 2020 to November 20, 2020 in southwestern Iran. Descriptive analyses included: sex ratio of deaths, mean and standard deviation of quantitative variable of age at the time of death, and specific ages-sex mortality rates. Years of life lost due to COVID-19 were estimated using standard life expectancy and lifetime table of the World Health Organization in 2015.
Results: The number of deaths due to COVID-19 was 938 cases. The sex ratio of mortality (male to female) was 1.2, and the people over the age of 80 years had the highest mortality rates in both sexes. The total number of years of life lost was 13205 years, and the 60-69 age group had the highest years of life lost.
Conclusion: Based on the findings of our study, health policymakers need to implement timely strategies and plans to reduce deaths especially for the possibleadvent of the next wave of COVID-19.

Keywords

  1. Moftakhar L, Seif M. The Exponentially Increasing Rate of Patients Infected with COVID-19 in Iran. Archives of Iranian medicine. 2020;23(4):235-8.
  2. Moftakhar L, Mozhgan S, Safe MS. Exponentially Increasing Trend of Infected Patients with COVID-19 in Iran: A Comparison of Neural Network and ARIMA Forecasting Models. Iranian Journal of Public Health. 2020;49:92-100.
  3. Honarvar M, Roshandel G, Shirzad-Aski H, Tabarraei A, Tahamtan A, Ghelichi-Ghojogh M, et al. Epidemiological and clinical characteristics of the COVID-19 epidemic and associated factors for mortality in Golestan province, Iran: A retrospective cohort study. Journal of Preventive Medicine and Hygiene. 2021:E298-E304.
  4. Kalteh EA, Sofizadeh A, Fararooei M, Ghojogh MG, Aljalili S. Measures of Mortality in Coronavirus (COVID-19) Compared with SARS and MERS. Journal of Cellular and Molecular Anesthesia. 2020;5(2):97-101.
  5. Khezri R, Valizadeh R, Nozad P. Achieving Vaccine for COVID-19: Hope for AIDS and Hepatitis C Vaccine? Journal of Cellular and Molecular Anesthesia. 2021;6(1):106-7.
  6. Hassan SA, Sheikh FN, Jamal S, Ezeh JK, Akhtar A. Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment. Cureus. 2020;12(3).
  7. Leung C. Clinical features of deaths in the novel coronavirus epidemic in China. Reviews in Medical Virology. 2020:e2103.
  8. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020:200642.
  9. Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. The Lancet infectious diseases. 2020.
  10. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. International journal of infectious diseases. 2020.
  11. Huang X, Wei F, Hu L, Wen L, Chen K. Epidemiology and clinical characteristics of COVID-19. Archives of Iranian medicine. 2020;23(4):268-71.
  12. Jo M-W, Go D-S, Kim R, Lee SW, Ock M, Kim Y-E, et al. The Burden of Disease due to COVID-19 in Korea Using Disability-Adjusted Life Years. Journal of Korean Medical Science. 2020;35(21).
  13. Gènova-Maleras R, Catalá-López F, de Larrea-Baz NF, Álvarez-Martín E, Morant-Ginestar C. The burden of premature mortality in Spain using standard expected years of life lost: a population-based study. BMC public health. 2011;11(1):787.
  14. Sankoh O, Sharrow D, Herbst K, Whiteson Kabudula C, Alam N, Kant S, et al. The INDEPTH standard population for low-and middle-income countries, 2013. Global health action. 2014;7(1):23286.
  15. World Health Organization. National burden of disease studies: apratical guide. 2nd ed. Geneva: World Health Organization;. 2001.
  16. Nurchis MC, Pascucci D, Sapienza M, Villani L, D’Ambrosio F, Castrini F, et al. Impact of the Burden of COVID-19 in Italy: Results of Disability-Adjusted Life Years (DALYs) and Productivity Loss. International Journal of Environmental Research and Public Health. 2020;17(12):4233.
  17. i Arolas HP, Myrskylä M, Lo A, Acosta E, Casasnovas GL, Nicodemo C, et al. Global years of life lost to COVID-19. medRxiv. 2020.
  18. Azarbakhsh H, Mirahmadizadeh A, Rostami M. Mortality Rate and Years of Life Lost, Due to Premature Death Caused by COVID-19, In Iran, Ahwaz Jundishapur University of Medical Sciences. 2020.
  19. Rommel A, von der Lippe E, Plass D, Ziese T, Diercke M, an der Heiden M, et al. The COVID-19 Disease Burden in Germany in 2020: Years of Life Lost to Death and Disease over the Course of the Pandemic. Deutsches Ärzteblatt International. 2021;118(9):145.
  20. Vieira A, Ricoca VP, Aguiar P, Sousa P, Nunes C, Abrantes A. Years of life lost by COVID-19 in Portugal and comparison with other European countries in 2020. BMC public health. 2021;21(1):1-8.
  21. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020.
  22. Chowell G, Mizumoto K. The COVID-19 pandemic in the USA: what might we expect? The Lancet. 2020;395(10230):1093-4.
  23. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. Jama. 2020;323(18):1775-6.